BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29148955)

  • 1. Experience of Tubo-Ovarian Abscess: A Retrospective Clinical Analysis of 318 Patients in a Single Tertiary Center in Middle Turkey.
    Inal ZO; Inal HA; Gorkem U
    Surg Infect (Larchmt); 2018 Jan; 19(1):54-60. PubMed ID: 29148955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the Need for Invasive Intervention in Tubo-ovarian Abscess Be Predicted? The Implication of C-reactive Protein Measurements.
    Ribak R; Schonman R; Sharvit M; Schreiber H; Raviv O; Klein Z
    J Minim Invasive Gynecol; 2020 Feb; 27(2):541-547. PubMed ID: 31479751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience of tubo-ovarian abscess in western Turkey.
    Güngördük K; Guzel E; Asicioğlu O; Yildirim G; Ataser G; Ark C; Gulova SS; Uzuncakmak C
    Int J Gynaecol Obstet; 2014 Jan; 124(1):45-50. PubMed ID: 24139472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of ultrasonographic tubo-ovarian abscess morphology in predicting whether patients will require surgical treatment.
    Kinay T; Unlubilgin E; Cirik DA; Kayikcioglu F; Akgul MA; Dolen I
    Int J Gynaecol Obstet; 2016 Oct; 135(1):77-81. PubMed ID: 27381446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prediction of surgical intervention in patients with tubo-ovarian abscess.
    Hwang JH; Kim BW; Kim SR; Kim JH
    J Obstet Gynaecol; 2022 Jan; 42(1):97-102. PubMed ID: 33629630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-guided drainage management of tubo-ovarian abscess and the role of C-reactive protein measurements in monitoring treatment response: a single-center experience.
    Türen Demir E; Energin H; Kilic F
    Arch Gynecol Obstet; 2023 Oct; 308(4):1321-1326. PubMed ID: 37389642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Intervention in Patients with Tubo-Ovarian Abscess: Clinical Predictors and a Simple Risk Score.
    Fouks Y; Cohen A; Shapira U; Solomon N; Almog B; Levin I
    J Minim Invasive Gynecol; 2019; 26(3):535-543. PubMed ID: 29966713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intrauterine device presence and other factors in medical treatment success of tuboovarian abscess.
    Tugrul Ersak D; Ersak B; Kokanalı MK
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101983. PubMed ID: 33189945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuboovarian abscess. Factors associated with operative intervention after failed antibiotic therapy.
    Greenstein Y; Shah AJ; Vragovic O; Cabral H; Soto-Wright V; Borgatta L; Kuohung W
    J Reprod Med; 2013; 58(3-4):101-6. PubMed ID: 23539877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience.
    Demirtas O; Akman L; Demirtas GS; Hursitoglu BS; Yilmaz H
    Arch Gynecol Obstet; 2013 Mar; 287(3):519-23. PubMed ID: 23104053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and treatment outcomes of patients with tubo-ovarian abscess at a tertiary care hospital in Northern Taiwan.
    Kuo CF; Tsai SY; Liu TC; Lin CC; Liu CP; Lee CM
    J Microbiol Immunol Infect; 2012 Feb; 45(1):58-64. PubMed ID: 22154676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of neutrophil to lymphocyte ratio in prediction of medical treatment failure for tubo-ovarian abscess.
    Alay I; Kaya C; Karaca I; Eren E; Hosgoren M; Aslanova F; Cengiz H; Ekin M; YaSar L
    J Obstet Gynaecol Res; 2019 Jun; 45(6):1183-1189. PubMed ID: 30907061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of severe pelvic inflammatory disease, pyosalpinx and tubo-ovarian abscess.
    Kim HY; Yang JI; Moon C
    J Obstet Gynaecol Res; 2015 May; 41(5):742-6. PubMed ID: 25363239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complicated Clinical Course and Poor Reproductive Outcomes of Women with Tubo-Ovarian Abscess after Fertility Treatments.
    Fouks Y; Cohen Y; Tulandi T; Meiri A; Levin I; Almog B; Cohen A
    J Minim Invasive Gynecol; 2019 Jan; 26(1):162-168. PubMed ID: 29890350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum procalcitonin levels together with clinical features and inflammatory markers in women with tubo-ovarian abscess for discriminating requirements for surgery for full recovery.
    Karaca K; Ozkaya E; Kurek Eken M; Uygun I; Kopuk SY; Alpay M
    J Obstet Gynaecol; 2018 Aug; 38(6):818-821. PubMed ID: 29523046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubo-ovarian abscess management in our clinic.
    Öncü N; Buhur A; Biçer HG
    Ginekol Pol; 2022 Nov; ():. PubMed ID: 36378129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubo-Ovarian Abscesses: Epidemiology and Predictors for Failed Response to Medical Management in an Asian Population.
    Chan GMF; Fong YF; Ng KL
    Infect Dis Obstet Gynecol; 2019; 2019():4161394. PubMed ID: 31274977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study.
    Kapustian V; Namazov A; Yaakov O; Volodarsky M; Anteby EY; Gemer O
    Arch Gynecol Obstet; 2018 May; 297(5):1201-1204. PubMed ID: 29478102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Minimally Invasive Management of Tubo-ovarian Abscess: A Systematic Review.
    Goje O; Markwei M; Kollikonda S; Chavan M; Soper DE
    J Minim Invasive Gynecol; 2021 Mar; 28(3):556-564. PubMed ID: 32992023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Predictors of Failed Medical Treatment in Patients with Tubo-ovarian Abscess: External Validation of a Recently Published Risk Score.
    Jalloul RJ; Thomas M; Ward C; Pedroza C
    J Minim Invasive Gynecol; 2022 May; 29(5):649-655. PubMed ID: 35051659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.